Skip to main content

FARADAY FUTURE INTELLIGENT ELECTRIC INC.

For the period ended Dec 31, 2025. Filed Mar 31, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 31, 2026

FFAI$0.28-8.9%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 9B. Other Information

Robotics Initiative

During 2025, the Company began evaluating a robotics initiative as part of its broader strategy to explore the application of artificial intelligence across multiple technology domains. As of December 31, 2025, this initiative remained at an early stage and was not associated with material operations, revenue-generating activities, or commercial deployments.

The robotics initiative is intended to assess potential long-term opportunities involving intelligent automation, AI-enabled physical systems, and software-driven robotics platforms. Management believes advancements in artificial intelligence, perception systems, and computing efficiency may support broader adoption of robotics technologies across industrial, logistics, manufacturing, and service-oriented applications over time.

As part of this initiative, the Company has conducted preliminary research focused on identifying potential use cases, evaluating technical feasibility, and assessing strategic alignment with its existing AI development efforts. These activities have included internal conceptual studies, early-stage design evaluation, and high-level market assessments. As of December 31, 2025, the Company had not entered into material manufacturing arrangements, customer contracts, or commercialization agreements related to robotics.

The robotics initiative is being evaluated as a potential future area of development rather than as an operating business. Any advancement beyond exploratory assessment remains subject to further technical validation, availability of capital, internal governance approvals, and market conditions. The Company has not committed to a development, product launch, or commercialization timeline and may modify, delay, or discontinue the initiative at its discretion.

Given the early stage of evaluation as of December 31, 2025, the robotics initiative did not require significant capital investment, dedicated manufacturing infrastructure, or expanded workforce resources. Accordingly, the Company did not consider the initiative to be material to its operations for the year ended December 31, 2025.

Subsequent to year end, the Company began delivering an initial batch of humanoid robot products to customers at the end of February 2026. The Company is also exploring development of an EAI Brain and open-source, open-platform framework, as well as a decentralized data-collection factory.

Consulting Services Agreement

On March 6, 2023, the Company entered into a Consulting Services Agreement (the “Consulting Services Agreement”) with FF Global, effective as of February 1, 2023. Pursuant to the Consulting Services Agreement, FF Global shall provide consultation and integrate resources to assist the Company in achieving its strategic goals, including to (i) assist the Company in developing its funding strategy; (ii) assist the Company in developing its value return& management strategy; (iii) consult on and integrate stockholder relations and stockholder resources; (iv) provide support on communications regarding stockholders meetings; (v) develop the Company’s existing stockholder financing strategy, including retail investors and others; (vi) assist the Company in risk management strategy; and (vii) assist in capability build up & operation strategy. The Consulting Services Agreement has an initial term of 12 months and automatically renews for successive 12 month periods unless earlier terminated in accordance with the terms thereof. Effective March 6, 2025, the Consulting Services Agreement renewed automatically until March 6, 2026.

As consideration, the Company agreed to pay FF Global a monthly fee of $0.2 million per month, due and payable on the last day of each month beginning on March 31, 2023, as well as reimburse FF Global for all reasonable and documented out-of-pocket travel, legal, and other out-of-pocket expenses incurred in connection services pursuant to the Consulting Services Agreement, (including reasonable fees and disbursements of FF Global’s external legal counsel), which out-of-pocket expenses shall not exceed $0.05 million without the prior written consent of the Company (which consent shall be in the sole and absolute discretion of the Company).

The description of the Consulting Agreement in this Item 9B is qualified in its entirety by reference to its terms, as detailed in Note 9, Related Party Transactions—which also includes the payment information—and as filed as Exhibit 10.47 to this Form 10-K.

Insider Trading Policies and Procedures

The Company maintains an Insider Trading and Confidentiality Policy to ensure compliance with federal securities laws, including SEC Rule 10b5-1 and Section 10(b) of the Securities Exchange Act of 1934. This Policy applies to employees, officers, directors, independent contractors, and consultants and is designed to prevent the unlawful use of material nonpublic information in securities trading. It outlines i) prohibited activities, including restrictions on trading and the sharing of material nonpublic information; ii) trading restrictions, which govern when and how Company securities may be traded, including pre-clearance requirements, blackout periods, and designated trading windows; and iii) compliance and enforcement measures, specifying adherence requirements, periodic reviews, and potential consequences for violations.

The Policy prohibits:

Trading in Company securities while in possession of material nonpublic information.

Tipping or sharing confidential Company information with third parties, including family and friends.

Engaging in short sales, hedging transactions, or margin trading involving Company securities.

Trading Restrictions:

Directors, executive officers, and designated employees (including vice presidents and above) may only trade during approved trading windows, which begin one full trading day after the public release of quarterly results and end ten trading days before the end of the subsequent quarter.

Pre-clearance is required at least 48 hours in advance of any trade, and transactions must be executed within 48 hours of approval. If material nonpublic information is obtained before execution, the trade must not proceed.

The Company may impose event-specific blackout periods to restrict trading when material developments are pending. These restrictions apply to all employees, officers, and directors with access to material nonpublic information.

Trading under Rule 10b5-1 plans is permitted if established in good faith, at a time when the individual is not in possession of material nonpublic information, and is pre-approved by the Legal Department and Executive Chairperson (or designee).

Compliance & Enforcement:

Violations may result in disciplinary action, termination, and potential civil or criminal penalties.

Employees are required to acknowledge the Policy upon hiring and review it annually.

The Legal Department and Executive Chairperson (or designee) are responsible for enforcing the Policy and monitoring compliance.

The Policy is reviewed and updated by the Board of Directors as necessary to ensure compliance with evolving regulations and Company policies.

Insider Trading Arrangements

During the three months ended December 31, 2025, none of the Company’s directors or officers (as defined in Rule 16a-1(f) of the Exchange Act)adopted, modified, orterminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement” as such terms are defined under Item 408 of Regulation S-K.

Amendment to a certain securities purchase agreement

As previously disclosed under the current report on Form 8-K filed with the SEC on February 5, 2026, on February 4, 2026, the Company entered into a Securities Purchase Agreement (the “AIXC SPA Agreement”) with an accredited investor (the “AIXC Investor”), pursuant to which the Company has agreed to sell, and the Investor has agreed to purchase, $10 million (the “Subscription Amount”) of Class A Common Stock at a per share price equal to 100% of the closing price of Class A Common Stock (such per share price, the “Initial Price” and such number of shares of Common Stock issued thereunder, the “Subject Shares”, together with the Class A Common Stock issuable upon conversion of the Warrant (as defined below), the “Securities”) immediately prior to the closing date (the “AIXC Closing Date”). Pursuant to the AIXC SPA Agreement, the Company agreed to issue certain True-Up Shares to the Investor in the event of a Dilutive Issuance (a “True-Up Issuance”). Capitalized terms not defined herein shall have the meaning set forth in the Original Report..

Warrant

The Warrant will have a term of two years from the Closing Date and is exercisable immediately after completion of delivery of the 500 th FX Super One vehicle to customers by the Company, at an exercise price of $1.50 per share (the “Warrant Shares”).

Exercise Limitations

The AIXC Investor will not have the right to exercise any portion of the Warrant to the extent that, after giving effect to such exercise, the AIXC Investor (together with certain related parties) would beneficially own in excess of 9.99% of total number of shares of Class A Common Stock outstanding immediately after giving effect to such exercise.

At any time before the Company obtains stockholder approval in connection with the transaction contemplated under the AIXC SPA Agreement, or the financial viability exception pursuant to Nasdaq Rule 5635(d) for the issuance of the Securities under the AIXC SPA Agreement, then the Company may not issue Warrant Shares, which, when aggregated with the Subject Shares issued pursuant to the AIXC SPA Agreement (as amended by the Amendment), subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations, exceed the 19.99% of the total outstanding Class A Common Stock of the Company as of the date of the AIXC SPA Agreement.

The foregoing summaries of the Warrant and the Amendment do not purport to be complete and are subject to, and are qualified in their entirety by, the full text of the form of Warrant and the Amendment, which are filed as Exhibits 4.28 and 10.108, respectively, to this annual report on Form 10-K and are incorporated herein by reference.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.